TITLE

Immunization with a Peptide Containing MHC Class I and II Epitopes Derived from the Tumor Antigen SIM2 Induces an Effective CD4 and CD8 T-Cell Response

AUTHOR(S)
Kissick, Haydn T.; Sanda, Martin G.; Dunn, Laura K.; Arredouani, Mohamed S.
PUB. DATE
April 2014
SOURCE
PLoS ONE;Apr2014, Vol. 9 Issue 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens. Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies. Using humanized transgenic mice we found that the 9aa HLA-A*0201 epitope, SIM2237–245, was effective at inducing an antigen specific response against SIM2-expressing prostate cancer cell line, PC3. Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN-γ response in CD8 T cells to the HLA-A*0201-restricted SIM2237–245 epitope, and an IL-2 response by CD4 T cells to the SIM2240–254 epitope. This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells. Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.
ACCESSION #
95818017

 

Related Articles

  • T-Cell Receptor-Like Antibodies: Targeting the Intracellular Proteome Therapeutic Potential and Clinical Applications. Cohen, Maya; Reiter, Yoram // Antibodies (2073-4468); 

    Major histocompatibility complex (MHC) class I molecules are key in the immune response against malignant cells by shaping the T-cell repertoire and presenting peptides from endogenous antigens to CD8+ cytotoxic T cells. Because of their unique specificity, MHC-peptide complexes are a desirable...

  • CD4+ T cell lineage integrity is controlled by the histone deacetylases HDAC1 and HDAC2. Boucheron, Nicole; Tschismarov, Roland; Goeschl, Lisa; Moser, Mirjam A; Lagger, Sabine; Sakaguchi, Shinya; Winter, Mircea; Lenz, Florian; Vitko, Dijana; Breitwieser, Florian P; Müller, Lena; Hassan, Hammad; Bennett, Keiryn L; Colinge, Jacques; Schreiner, Wolfgang; Egawa, Takeshi; Taniuchi, Ichiro; Matthias, Patrick; Seiser, Christian; Ellmeier, Wilfried // Nature Immunology;May2014, Vol. 15 Issue 5, p439 

    Molecular mechanisms that maintain lineage integrity of helper T cells are largely unknown. Here we show histone deacetylases 1 and 2 (HDAC1 and HDAC2) as crucial regulators of this process. Loss of HDAC1 and HDAC2 during late T cell development led to the appearance of major histocompatibility...

  • MHC Restriction. Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p444 

    The entry explains major histocompatibility complex (MHC) restriction. Because of the nature of α β T cell receptor, the characteristic of T lymphocytes when they are bound to a particular allelic form of a MHC molecule, is to recognize foreign peptides. Both the CD4+ and CD8+recognize...

  • Split T Cell Tolerance against a Self/Tumor Antigen: Spontaneous CD4+ but Not CD8+ T Cell Responses against p53 in Cancer Patients and Healthy Donors. Tsuji, Takemasa; Matsuzaki, Junko; Ritter, Erika; Miliotto, Anthony; Ritter, Gerd; Odunsi, Kunle; Old, Lloyd J.; Gnjatic, Sacha // PLoS ONE;2011, Vol. 6 Issue 8, p1 

    Analyses of NY-ESO-1-specific spontaneous immune responses in cancer patients revealed that antibody and both CD4+ and CD8+ T cell responses were induced together in cancer patients. To explore whether such integrated immune responses are also spontaneously induced for other tumor antigens, we...

  • Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy. Teramoto, Koji; Ohshio, Yasuhiko; Fujita, Takuya; Hanaoka, Jun; Kontani, Keiichi // Journal of Cancer Research & Clinical Oncology;May2013, Vol. 139 Issue 5, p861 

    Purpose: Simultaneous activation of T helper 1 (Th1) cell function has crucial roles in induction of potent cytotoxic T lymphocyte (CTL) responses in cancer immunotherapy. Here, we investigated whether dendritic cell (DC)-based vaccines loaded with both tumor-associated antigen (TAA)-derived MHC...

  • Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy. Van Acker, Heleen H; Anguille, Sébastien; Van Tendeloo, Viggo F; Lion, Eva // OncoImmunology;Aug2015, Vol. 4 Issue 8, p00 

    Gamma delta (γδ) T cells are the all-rounders of our immune-system with their major histocompatibility complex-unrestricted cytotoxicity, capacity to secrete immunosti-mulatory cytokines and ability to promote the generation of tumor antigen-specific CD8+and CD4+T cell responses. Dendritic...

  • CD4+ T-Cell Help Is Required for Effective CD8+ T Cell-Mediated Resolution of Acute Viral Hepatitis in Mice. Trautmann, Tanja; Kozik, Jan-Hendrik; Carambia, Antonella; Richter, Kirsten; Lischke, Timo; Schwinge, Dorothee; Mittrücker, Hans-Willi; Lohse, Ansgar W.; Oxenius, Annette; Wiegard, Christiane; Herkel, Johannes // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Cytotoxic CD8+ T cells are essential for the control of viral liver infections, such as those caused by HBV or HCV. It is not entirely clear whether CD4+ T-cell help is necessary for establishing anti-viral CD8+ T cell responses that successfully control liver infection. To address the role of...

  • Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8+ T lymphocytes. Tischer, Sabine; Kaireit, Till; Figueiredo, Constança; Hiller, Oliver; Maecker-Kolhoff, Britta; Geyeregger, Renè; Immenschuh, Stephan; Blasczyk, Rainer; Eiz-Vesper, Britta // International Immunology;Sep2012, Vol. 24 Issue 9, p561 

    Multimers of soluble peptide-major histocompatibilty complex (pMHC) molecules are used in both basic and clinical immunology. They allow the specific visualization and isolation of antigen-specific T cells from ex vivo samples. Adoptive transfer of antigen-specific T cells sorted by pMHC...

  • Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes. Hui, Daniel J; Basner-Tschakarjan, Etiena; Chen, Yifeng; Davidson, Robert J; Buchlis, George; Yazicioglu, Mustafa; Pien, Gary C; Finn, Jonathan D; Haurigot, Virginia; Tai, Alex; Scott, David W; Cousens, Leslie P; Zhou, Shangzhen; De Groot, Anne S; Mingozzi, Federico // Molecular Therapy;Sep2013, Vol. 21 Issue 9, p1 

    Immune responses directed against viral capsid proteins constitute a main safety concern in the use of adeno-associated virus (AAV) as gene transfer vectors in humans. Pharmacological immunosuppression has been proposed as a solution to the problem; however, the approach suffers from several...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics